Definitions
Sorry, no definitions found. You may find more data at celator.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Celator.
Examples
-
In 1986, he founded The Celator — a monthly journal about ancient coins.
A Time to Speak Out – Will Ancient Coins from Italy be Restricted? : Coin Collecting News 2010
-
In 1986, he founded The Celator — a monthly journal about ancient coins.
-
In 1986, he founded The Celator — a monthly journal about ancient coins.
A Time to Speak Out – Will Ancient Coins from Italy be Restricted? : Coin Collecting News 2010
-
In 1986, he founded The Celator — a monthly journal about ancient coins.
-
Celator Pharmaceuticals today announced data from animal studies demonstrating the superior bone marrow uptake of CPX-351 (Cytarabine: Daunorubicin) Liposome Injection, its lead clinical-stage program, as well as the enhanced circulation kinetics and efficacy of its preclinical hydrophobic docetaxel prodrug nanoparticle (HDPN) formulation were presented at the 101st Annual Meeting of the American Association for Cancer Research in Washington, DC (Abstracts 3698 and 5534).
Nano Tech Wire 2010
-
Dec. 7/PRNewswire/-- Celator Pharmaceuticals today announced that interim safety and efficacy data from its Phase 2 multicenter, randomized, open-label clinical
WN.com - Articles related to AFRICA: High hopes as new TB vaccine proves effective 2010
-
Celator Pharmaceuticals today announced that the first patient has been treated in a randomized Phas ...
THE MEDICAL NEWS Editors 2010
-
Net provides this medical information service in accordance with these Physical exercise and computer use may help protect against mild cognitive impairment: Mayo Clinic Celator Pharmaceuticals presents data on CPX-351 Liposome Injection and HDPN formulation Miss. lawmakers want voters to have say on health coverage mandate NeoStem signs Collaborative Research Agreement with ImmuneRegen BioSciences
THE MEDICAL NEWS Editors 2010
-
Based on the applications of CombiPlex and the proprietary nanoparticle prodrug delivery platform, Celator is positioned to advance a broad pipeline of cancer therapies involving both previously approved and novel drug agents.
Nano Tech Wire 2010
-
"This research continues to expand our understanding of the activity and potential clinical benefits of improved cancer therapeutics based on our proprietary technologies; the CombiPlex platform and the nanoparticle prodrug delivery platform," said Scott Jackson, chief executive officer of Celator Pharmaceuticals.
Nano Tech Wire 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.